Formulation and Evaluation of Mouth Dissolving Tablets of Piroxicam

Size: px
Start display at page:

Download "Formulation and Evaluation of Mouth Dissolving Tablets of Piroxicam"

Transcription

1 Singh et al: Formulation and Evaluation of Mouth Dissolving Tablets of Piroxicam 2941 International Journal of Pharmaceutical Sciences and Nanotechnology Volume 8 Issue 3 July September 2015 Research Paper MS ID: IJPSN SINGH Formulation and Evaluation of Mouth Dissolving Tablets of Piroxicam Sudarshan Singh*, S.S. Shyale and G. Bhosale Department of Pharmaceutics, HSBPVT s, College of Pharmacy, Kashti, Maharastra, India. Received January 12, 2015; accepted May 13, 2015 ABSTRACT Piroxicam, a non-steroidal anti-inflammatory agent, is widely used in rheumatoid arthritis, osteoarthritis, musculoskeletal disorders, dysmenorrhoeal and post-operative pain. It has poor bioavailability due to its inherent properties. The objective of present study is to enhance water solubility of Piroxicam by solid dispersion technique and to develop novel method of preparing compressed tablets for Piroxicam with high porosity which dissolves rapidly in mouth, using camphor as sublimating agent and super disintegrants such as Crosscarmellose sodium and sodium starch glycollate. The tablets were evaluated for hardness, thickness, friability, weight variation, wetting time, disintegration time, drug content and in vitro drug KEYWORDS: Piroxicam; β-cyclodextrin; Crosscarmellose Sodium; Sodium Starch Glycollate. release. Optimized formulation was evaluated for stability according to ICH guideline. All tablets had hardness in range of kg/cm2 and friability of all formulations was less than 1.0%. Weight variation and drug content were within USP limits. A stability study for optimized F6 formulation 40 C / 75 % RH for 30 days showed little change in drug content. Therefore, it is concluded that enhance solubility and increased levels of the super disintegrants Cross carmellose sodium and sodium starch glycollate increases the rate of Piroxicam release. Camphor decreases disintegration time of tablets and create high porosity which dissolve rapidly in mouth and could be industrially feasible. Introduction Many patients, especially elderly find it difficult in swallowing tablets, capsules, fluids and thus do not comply with prescription, which results in high incidence of non-compliance oriented research has resulted in bringing out many safer and newer drug delivery systems. Rapidly disintegrating/dissolving tablet is one of such example, for the reason of rapid disintegration or even with saliva. Significance of this drug delivery system includes administration without water, accuracy of dosage, ease of portability, alternative to liquid dosage forms, ideal for paediatric and geriatric patients and rapid onset of action (Prajapati and Ratnakar, 2009). Piroxicam is chemically, 4-hydroxyl-2-methyl-N-2- pyridinyl-2h-1,2-benzothiazine 3-carboxamide-1,1-dioxide. It is a selective cyclooxygenase-2 inhibitor used in the treatment of rheumatoid arthritis, osteoarthritis and other joint diseases. The poor aqueous solubility of the drug gives rise to difficulties in the formulation rates. Therefore, in the present study, we made an attempt to increase the water solubility of Piroxicam by solid dispersion techniques by forming inclusion complex of drug β-cyclodextrin by kneading method and prepare mouth dissolving tablets of Piroxicam in the oral cavity with an emphasis on enhanced dissolution rate for improved patient compliance (Widjaja andsetyawan, 2013). Materials and Methods Piroxicam was received as a gift sample from Matrix PharmaPvt. Ltd., Aurangabad Maharashtra. CrosscarmelloseSodium(CCS) and Sodium Starch Glycollate (SSG) was received as a gift sample from Signet Chemical Co Ltd, BandraKurla Complex, Mumbai β- Cyclodextrin (β-cd) was procurred from Yash scientific pune and other materials used were of analytical grade and procured from commercial sources. Methods Solubility enhancement by using β-cyclodextrin: Inclusion complexes were prepared by kneading method. Piroxicam with β-cyclodextrin in different molar ratios (1:1, 1:1.5, 1:2) was used. β-cyclodextrin was added to the mortar, small quantity of distilled water was added while triturating to obtain a homogenous paste. The drug was slowly added to the paste and mixture triturated for one hour. During the process, the water content of the paste was empirically adjusted to maintain the consistency of the paste. The paste was dried at 40 o C for 24 hr, pulverized by passing through sieve no. 85 and stored in a desiccators till further use (Radha et al., 2010). Drugexcipients compatibility studies: The FT-IR spectrum of Piroxicam, physical mixture of Piroxicam with sodium starch glycollate and Crosscarmellose sodium were analysed to verify the compatibility between the pure drug and polymers using FT-IR (Make Varian 2941

2 2942 Int J Pharm Sci Nanotech Vol 8; Issue 3 July September 2015 Cary, Model-510) by KBr disc method. The procedure consisted of dispersing a sample (drug alone or mixture of drug and polymers) in KBr and compressing into discs by applying a pressure of 5 tons for 5 min in a hydraulic press. The pellet was placed in the light path and the spectrum was obtained, to identify functional groups and bands of drug or its mixture (Patrick and Sinko, 2009).TheDSC thermogram of the Piroxicam and physical mixtures of Piroxicam with sodium starch glycollate and Crosscarmellose sodium were obtained using Shimadzu DSC-60 (Shimadzu Limited Japan) by heating at a scanning rate of 10 C/min over a temperature range 50 C C under nitrogen environment(patrick and Sinko, 2009). DSC thermogram of pure Piroxicam and formulation were obtained to verify chemical interaction between drug and excipients. Preparation of Mouth dissolving tablets: The mouth dissolving tablets were prepared by direct compression method. The composition of mouth dissolving tablets is presented in Table 1. Drug β-cd complex and excipients were accurately weighed and mixed. Tablets were compressed using 6 mm flat punch Tablet press 10 station compression machine (Cemach R and D) (Bhowmik et al., 2009). Hardness of the tablets between was kept between Kg/cm 2. Tablet weight was maintained at 150 mg. All the product and process variables were kept as practically constant. TABLE 1 Composition of prepared mouth dissolving tablets. Ingredients (in mg) Drug β-cd (eq. to 20mg ) Batch Codes F1 F2 F3 F4 F5 F6 F7 F8 F CCS SSG Sucrose Camphor Aerosil Total (mg) Pre-compression evaluation parameter: The powder bed was evaluated for the blend property such as Bulk density, Tapped density, Carr s index, Hausner s ratio and Angle of repose (Lachman and Liberman, 2009). Evaluation of mouth dissolving tablets: Mouth dissolving tablets of Piroxicam were evaluated for their post-compression parameters such as weight variation, hardness, thickness, friability, uniformity of weight and drug content uniformity (Bhowmik et al., 2009; Lachman and Liberman, 2009). Disintegration test: Disintegration of rapidly disintergrating oral tablets is achieved in the mouth owing to the action of saliva; however amount of saliva in the mouth is limited. A modified method was used to determine disintegration time of the tablets. A cylindrical vessel was used in which 10 mesh a screen was placed in such a way that only 2 ml of disintegrating medium would be placed below the sieve. To determine disintegration time, 6 ml of phosphate buffer (ph 6.8), was placed inside the vessel in such a way that 4 ml of the media was below the sieve and 2 ml above the sieve. Tablet was placed on the sieve and the whole assembly was then placed on a shaker. The time at which all the particles pass through the sieve was taken as a disintegration time of the tablet (Ashishet al., 2011). Wetting time: A Petri dish containing 6 ml of 6.8 phosphate buffer was used. Tissue paper folded twice was kept in the dish and a tablet was placed on it. A small quantity of Amaranth red colour was added on the upper surface of the tablet. Time required for the upper surface of the tablet to become red was noted as the wetting time of the tablet (Ashish et al., 2011). In vitro drug release profile of piroxicam: In-vitro release from rapidly disintegrating tablets of Piroxicam was determined using USP dissolution testing apparatus II (paddle method). The dissolution test was performed using 900 ml of 0.1 N HCl, ph 1.2 at 37 ± 0.5 C and 50 rpm (Ashish et al., 2011) specified amount of sample (5 ml) of the solution was withdrawn from the dissolution apparatus at different time intervals and the samples were replaced with fresh dissolution medium. Later the withdrawn sample was diluted to suitably with 0.1 N HCl, ph 1.2. Absorbance of these solutions was measured at 334 nm using a UV Visible double beam spectrophotometer (Jasco v-630). Cumulative percentage drug release was calculated using an equation obtained from a standard curve. Dissolution profile comparisons (using a similarity factor): A simple model independent approach uses a difference factor (f1) and a similarity factor (f2) to compare dissolution profiles. The difference factor (f1) calculates the percent (%) difference between the two curves at each point and is a measurement to the relative error between the two curves. f1= {[Σn=1 n Rt Tt ]/ [Σt=1 n Rt ]} 100 Where n is the number of time point, Rt is the dissolution value of the reference batch at time t, and Tt is the dissolution value of the test batch at time t. The similarity factor (f2) is the logarithmic reciprocal square root transformation of the sum of squared error and is a measurement of the similarity in the percent (%) dissolution between the two curves. f2 = 50 log {[1+ ( 1/n) Σt=1n ( Rt Tt )2 ] } For the curves to be considered similar, f1 values should be close to 0 and f2 values should be close to 100. Generally, f1 values up to (0-15) and f2 values greater than 50 (50-100) ensures sameness or equivalence of the two curves and thus, of the performance of the test and reference products (Singhet al., 2009). The comparative dissolution was performed using Piroxicam 20mg. Statistical analysis: Results obtained for above disintegration time, wetting time and in vitro dissolution studies measurement are expressed as mean SEM (Standard Error Mean) and subjected to one-way analysis of variance (ANOVA) with P < 0.05 were considered to be statistically significant (Subrahmanyam, 2000).

3 Singh et al: Formulation and Evaluation of Mouth Dissolving Tablets of Piroxicam 2943 Stability study: To assess the drug and formulation stability, stability studies was performed according to ICH guideline. Optimized mouth dissolving tablets were sealed in aluminium packing and kept in humidity chamber maintained at 40 C and 75% RH for 90 days. Samples were analyzed for the drug content, surface ph, in vitro drug release study and other physicochemical propertiesat regular intervals(jens and Rhodes, 2009). Results and Discussion Solubility enhancement of Piroxicam using β-cyclodextrin: A complex of Piroxicam and β-cyclodextrin in different molar ratios (1:1, 1:1.5, and 1:2) were prepared. The solubility of Piroxicam: β-cd complex was studied. The solubility of 1:1 ratio is greater as compared to pure drug, 1:1.5 and 1:2 ratios. Results are presented in Fig. 1. Fig. 1. Solubility of piroxicam in different solvents at λmax 334 nm. Drugexcipients compatibility studies by FTIR: The result of FTIR spectra for pure drug is presented in Figure 2, the characteristic peaks of Piroxicam N-H stretch at cm 1, C-H stretch at cm 1, C=C stretch at cm 1 and C-N stretch at cm 1, OH bend at were not affected. Based on the findings of physical constants and spectrophoto-metrically analysis, the sample of Piroxicam was considered to be authentic. The result of FTIR spectra for optimized batch is presented in Figure 3, the characteristic peaks of Piroxicam N-H stretch at cm 1, C-H stretch at cm 1, C=C stretch at cm 1 and C-N stretch at cm 1, OH bend at were not affected. It was found that all excipients were compatible with Piroxicam. Drug excipients compatibility studies by DSC: DSC analysis was performed on Shimadzu DSC-60(Shimadzu Limited Japan). DSC thermogram of pure Piroxicam and mixture of drug with CCS and sucrose are presented in Figure 4 and 5 The DSC thermogram of Piroxicam showed an endothermic peak at C corresponding to its melting point. Melting point obtained experimental values is nearer to this value. The thermogram of drug with CCS and sucrose showed an endothermic peak at ºC which is similar to the melting point of the drug. Thermogram indicated that, the drug is compatible with the excipients CCS or sucrose or its mixture. Pre-compression evaluation: Bulk density and Tapped density were found in acceptable limit which indicated that the packing properties required during compression are adequate in all formulations. Carr s index indicated a good compressibility. Hausner s ratio and angle of repose were found in acceptable limit which implies good flow properties. The results were tabulated in Table 2. Evaluation of Mouth dissolving tablets: Tablets of formulation batches were evaluated for thickness, diameter, average weight, hardness, friability and drug contentsresults were tabulated in Table 3. The tablets mean thickness and diameters of all formulation was found to be in the range of 3.7 to 3.9 mm and 6.01 to 6.05 mm respectively. All batches pass weight variation test and found to be within range. The hardness is within the range of 2.8 to 3.1 kg/cm 2, it indicates that tablet have good mechanical strength.the tablets mean diameters and thickness of formulations were found to be in the range of 6.01 to 6.05 mm and 3.7 to 3.9 mm respectively. Friability was found to in the range of 0.45 to 0.89 %. The friability was less than 1% in all the formulations ensuring that the tablet were mechanically stable.the drug content were found to be between % ± 1.01 to % ± 1.05, indicates uniformity of blending and consistency. Fig. 2. FTIR spectrum of the piroxicam.

4 2944 Int J Pharm Sci Nanotech Vol 8; Issue 3 July September 2015 Fig. 3. FTIR spectrum of optimized batch F6. DSC mw Thermal Analysis Result Fig. 4. DSC Thermogram of piroxicam pure drug C Temp [C] TABLE 2 Evaluation of pre-compression parameters of tablet blends. Batch code Bulk density g/ml ± SD Tapped density g/ml ± SD Carr s index% Hausner s ratio Angle of repose ± SD F F F F F F F F F Note: Values are mean of three observation (n = 3) and Values in parenthesis are Standard Deviation (± SD) TABLE 3 Evaluation of physical properties of tablets. Batch Code Thickness Diameter Average weight of Tablet(mg) ± SD Hardness (kg/cm 2 ) ± SD Friability ± SD % Drug Contents ± SD % F F F F Table 3 Contd...

5 Singh et al: Formulation and Evaluation of Mouth Dissolving Tablets of Piroxicam 2945 Batch Code Thickness Diameter Average weight of Tablet(mg) ± SD Hardness (kg/cm 2 ) ± SD Friability ± SD % Drug Contents ± SD % F F F F F Note: Values are mean of three observation (n = 3) and Values in parenthesis are Standard Deviation (± SD) Disintegration time: The result of disintegration time is presented in Table 4. A modified method was used to evaluate the in vitro disintegration time because the disintegration rate obtained from conventional test does not appear to reflect the disintegration rate in humans. All batches pass the criteria for disintegration time. It was obtained that formulation batches had a disintegration time in the range of to ± 1.60 seconds. Formulations containing Crosscarmellose disintegrated faster than formulations containing sodium starch glycollate. Statistically the data was analysed by one way ANOVA at a P < It was found that the data at any point of time are significant at P < TABLE 4 Evaluation of various parameters of tablets (n = 3). Batch Code Disintegration time (s) ± SD Wetting Time (s) ± SD F F F F F F F F F Note: Values are mean of three observation (n = 3) and Values in parenthesis are Standard Deviation (± SD) Wetting time: The result of wetting time is presented in table 4. The dissolution process of a tablet depends on the wetting followed by disintegration of the tablet. The measurement of wetting time may be used as confirmatory test for evaluation of the mouth dissolving tablets. Mean wetting time was found to be in the range of to seconds, presented in Figure 5. Statistically the data was analysed by one way ANOVA at a P < It was found that the data at any point of time are significant at P < In vitro drug release studies: The result of in vitro drug release study is presented in Figure 6. The comparative study of dissolution profile of batch F1 to F3 shows that in absence of aerosil does not affect on dissolution, disintegration and wetting time. Further in F2 absence of camphor affect on dissolution and increases disintegration and wetting time of tablets. In batch F1, absence of both aerosil and camphor affected the dissolution, disintegration and wetting time. The drug release was found to be %, %, % respectively for batch F1, F2 and F3 within 15 min. The comparative study of dissolution profile of batch F4 to F6 shows that when increase concentration of superdisintegrants Crosscarmellose sodium, percentage drug release was also increased. The drug release was found to be %, % and % respectively for batch F4, F5 and F6 within 15 min. The comparative study of dissolution profile of batch F7 to F9 shows that when increase concentration of superdisintegrants, sodium starch glycollate. The percentage drug release was also increased. The drug release was found to be %, % and % respectively for batch F7, F8 and F9 within 15. Statistically the data was analyzed by one way ANOVA at a P < It was found that the data at any point of time are significant at P < Fig. 6. Comparative dissolution profile of batches F1 to F9. Dissolution profile Comparisons (Similarity Factor): The dissolution comparisons by model independent approach using a similarity factor f1 was found to be 8.24 and f2 found (Figure 8). The comparative study of dissolution profile shows that optimized F6 batch shows better drug release than the marketed tablets Mobicam (Cipla, Pvt. Ltd). The percentage drug release was shown in Figure 7. Tablet wetting initial Tablet wetting after sec Fig. 5. Wetting time of optimized batch F6.

6 2946 Int J Pharm Sci Nanotech Vol 8; Issue 3 July September 2015 by sublimation technique offers a suitable and practical approach in serving desired objectives of faster disintegration and dissolution characteristics. Accelerated stability study was carried out for optimized formulation F6 which showed no significant difference in the drug content, disintegration time, hardness, friability and in vitro dissolution studies which confirms the stability of the product. Results were statistically analyzed by one-way ANOVA at a p < It was found that, the data at any point of time are significant at p < Fig. 7. Comparative dissolution profile of F6 with reference. Accelerated stability studies: The tablets were studied for short term stability at 40 C 2 C and 75% 5 % RH conditions for the period of 90 days. Each tablet were individually weighed and wrapped in an aluminium foil and kept at above specified conditioned in stability chamber for 90 days. After 30, 60 and 90 days tablet samples were analyzed. The data obtained from stability studies indicates that batch F6 was stable and optimum formulation. Statistically the data was analyzed by oneway ANOVA at a p < It was found that, the data at any point of time are significant at p < Conclusions Mouth dissolving tablet of Piroxicam was formulated by using various superdisintegrants such as CrosscarmelloseSodium and Sodium Starch Glycollate in different proportions by sublimating agent like camphor. The solubility of Piroxicam is enhanced by inclusion complexes with β-cd as a drug carrier. Then the prepared inclusion complexes was characterized and evaluated by DSC and FT-IR. The disintegration time of formulation F6 was found to seconds. Wetting time studies showed that wetting time was rapid in formulations containing camphor followed by CCS and SSG. It was found that as the concentration of CCS and SSG was increases, then wetting time was reduces. The wetting time of F6 formulation was found to be seconds. In vitro disintegration of batch F6 gives rapid disintegration time and wetting time. Drug content was found to be 99.48%. Results of in vitro dissolution data shows that from formulation F1-F9, F6 gives the drug release up to 99.57% within 10 min. So F6 was considered as a best formulation. Batch F6 compared with reference standard Mobicam 20mg marketed tablet which show better release than reference tablet which is an ideal requirement of mouth dissolving formulation. As a result of this study, it may be concluded that the inclusion complexation technique may be useful to enhance solubility, dissolution rate and subsequently bioavailability of poorly soluble drug. The concept of formulating high porous orally disintegrating tablets of Piroxicam inclusion complexes using superdisintegrants Acknowledgements I express my most cordial and humble thanks to management of Hon. Shri. Babanrao Pachpute Vichardhara Trust Group of Institutions, College of Pharmacy, Kashti. Tal-Srigonda, Dist-Ahmednagar, for his necessary help and for his efforts to facilitate the use of the necessary instruments and materials required during the entire course of this research work. I am also grateful to Matrix Pharma Pvt. Ltd, Aurangabad. And Signet Chemical Co Ltd, Bandra Kurla Complex, Mumbai for providing me gift samples of Drug and Polymers. References Ashish P, Harsoliya MS, Pathan JK and Shruti S (2011). A Review Formulation of Mouth Dissolving tablet. Int J Pharm Clinic Sci, 1(1): 1-8. Bhowmik D, Chiranjib B, Krishnakanth, Pankaj, Chandira R M (2009). Fast Dissolving Tablet: An overview. J Chem and Pharm Res, 1(1): Jens TC and Rhodes C T (2009). Drug Stability Principle and Practice. Third edition, Volume 107 Marcel Deccker Series, pp LachmanL and Liberman HA (2009). The Theory and Practice of Industrial Pharmacy. 3 rd edition. pp Patrick M and Sinko J (2009). Physical Pharmacy and Pharmaceutical science. B.I. Publication Pvt. Ltd, 5th edition, pp-232. Prajapati BG and Ratnakar N (2009). A Review on recent Patents on Fast Dissolving Drug Delivery System. Int J Pharm Tech Res, 1(3): Radha M, Kanaka DD and Prameela R (2010). Preparation and Characterization of Zafirlukast -Cyclodextrin Complexes using Solid Dispersion Techniques.Int J Pharm Sci Res, 4(1): Singh SK, Borkhataria CH, Seth NR, Patel RP, Singh S, and Parmar G (2009). Formulation and in vitro Evaluation of Lansoprazole Micro pellets. Int J Pharm Tech Res, 1(4): Subrahmanyam CVS (2000). Text Book of Physical Pharmaceutics, 2 nd edition. pp Widjaja B and Setyawan D (2013). Development of Piroxicam Orally Disintegrating Tablets by Freeze Drying Method. Int J Pharm Pharm Sci, 5: Address correspondence to: Dr. Sudarshan Singh, Assistant Professor, Dept. of Pharmaceutics, H.S.B.P.V.T, Group of Institutions, College of Pharmacy, Kashti, Ahmednagar , Maharashtra, India. Ph: ; sudarshansinghi10@gmail.com

CHAPTER VI FACTORIAL STUDIES ON THE EFFECTS OF CYCLODEXTRINS AND SOLUTOL HS15 ON THE SOLUBILITY AND DISSOLUTION RATE OF EFAVIRENZ AND RITONAVIR

CHAPTER VI FACTORIAL STUDIES ON THE EFFECTS OF CYCLODEXTRINS AND SOLUTOL HS15 ON THE SOLUBILITY AND DISSOLUTION RATE OF EFAVIRENZ AND RITONAVIR CHAPTER VI FACTORIAL STUDIES ON THE EFFECTS OF CYCLODEXTRINS AND SOLUTOL HS15 ON THE SOLUBILITY AND DISSOLUTION RATE OF EFAVIRENZ AND RITONAVIR Efavirenz and ritonavir, two widely prescribed anti retroviral

More information

7. SUMMARY, CONCLUSION AND RECOMMENDATIONS

7. SUMMARY, CONCLUSION AND RECOMMENDATIONS 211 7. SUMMARY, CONCLUSION AND RECOMMENDATIONS Drug absorption from the gastro intestinal tract can be limited by various factors with the most common one being poor aqueous solubility and poor permeability

More information

Formulation and evaluation of immediate release salbutamol sulphate

Formulation and evaluation of immediate release salbutamol sulphate 5 Formulation, optimization and evaluation of immediate release layer of salbutamol sulphate Salbutamol is moderately selective beta (2)-receptor agonist similar in structure to terbutaline and widely

More information

Formulation and evaluation of sublingual tablets of lisinopril

Formulation and evaluation of sublingual tablets of lisinopril Journal of GROVER Scientific & Industrial AGARWAL: Research FORMULATION AND EVALUATION OF SUBLINGUAL TABLETS OF LISINOPRIL Vol. 71, June 2012, pp. 413-417 413 Formulation and evaluation of sublingual tablets

More information

FABRICATION AND EVALUATION OF GLIMEPIRIDE CORDIA DICHOTOMA G.FORST FRUIT MUCILAGE SUSTAINED RELEASE MATRIX TABLETS

FABRICATION AND EVALUATION OF GLIMEPIRIDE CORDIA DICHOTOMA G.FORST FRUIT MUCILAGE SUSTAINED RELEASE MATRIX TABLETS Int. J. Chem. Sci.: 7(4), 2009, 2555-2560 FABRICATION AND EVALUATION OF GLIMEPIRIDE CORDIA DICHOTOMA G.FORST FRUIT MUCILAGE SUSTAINED RELEASE MATRIX TABLETS HINDUSTAN ABDUL AHAD *, B. PRADEEP KUMAR, C.

More information

STABILITY STUDIES OF FORMULATED CONTROLLED RELEASE ACECLOFENAC TABLETS

STABILITY STUDIES OF FORMULATED CONTROLLED RELEASE ACECLOFENAC TABLETS Int. J. Chem. Sci.: 8(1), 2010, 405-414 STABILITY STUDIES OF FORMULATED CONTROLLED RELEASE ACECLOFENAC TABLETS V. L. NARASAIAH, T. KARTHIK KUMAR, D. SRINIVAS, K. SOWMYA, P. L. PRAVALLIKA and Sk. Md. MOBEEN

More information

Formulation and Development of Sustained Release Tablets of Valsartan Sodium

Formulation and Development of Sustained Release Tablets of Valsartan Sodium INTERNATIONAL JOURNAL OF ADVANCES IN PHARMACY, BIOLOGY AND CHEMISTRY Research Article Formulation and Development of Sustained Release Tablets of Valsartan Sodium G. Sandeep * and A. Navya Department of

More information

Formulation and Evaluation

Formulation and Evaluation Chapter-5 Formulation and Evaluation 5.1 OBJECTIVE After successful taste masking and solubility enhancement of drugs in preliminary studies, by using Mannitol Solid Dispersion, next step includes the

More information

Formulation and evaluation of fast dissolving tablet of aceclofenac

Formulation and evaluation of fast dissolving tablet of aceclofenac International Journal of Drug Delivery 2 (2010) 93-97 http://www.arjournals.org/ijdd.html Research article ISSN: 0975-0215 Formulation and evaluation of fast dissolving tablet of aceclofenac Sudhir Bhardwaj

More information

FORMULATION AND EVALUATION OF BISOPROLOL FUMARATE FAST DISSOLVING TABLET BY DIRECT COMPRESSION TECHNIQUES

FORMULATION AND EVALUATION OF BISOPROLOL FUMARATE FAST DISSOLVING TABLET BY DIRECT COMPRESSION TECHNIQUES Research Article Deshmukh ND,, 2012; Volume 1(5): 364-378 ISSN: 2277-8713 FORMULATION AND EVALUATION OF BISOPROLOL FUMARATE FAST DISSOLVING TABLET BY DIRECT COMPRESSION TECHNIQUES *N. D. DESHMUKH, R. R.

More information

Formulation and evaluation of oro-dispersible tablets of lafutidine

Formulation and evaluation of oro-dispersible tablets of lafutidine Available online at www.scholarsresearchlibrary.com Scholars Research Library Der Pharmacia Lettre, 2015, 7 (5):226-235 (http://scholarsresearchlibrary.com/archive.html) ISSN 0975-5071 USA CODEN: DPLEB4

More information

FORMULATION AND CHARACTERIZATION OF TELMISATAN SOLID DISPERSIONS

FORMULATION AND CHARACTERIZATION OF TELMISATAN SOLID DISPERSIONS International Journal of PharmTech Research CODEN (USA): IJPRIF ISSN : 974-434 Vol.2, No.1, pp 341-347, Jan-Mar 1 FORMULATION AND CHARACTERIZATION OF TELMISATAN SOLID DISPERSIONS Kothawade S. N. 1 *, Kadam

More information

Study of Disintegrant Property of Moringa Oleifera Gum and its Comparison with other Superdisintegrants

Study of Disintegrant Property of Moringa Oleifera Gum and its Comparison with other Superdisintegrants International Journal of ChemTech Research CODEN( USA): IJCRGG ISSN : 0974-4290 Vol. 3, No.3, pp 1119-1124, July-Sept 2011 Study of Disintegrant Property of Moringa Oleifera Gum and its Comparison with

More information

Available Online through Research Article

Available Online through Research Article ISSN: 0975-766X Available Online through Research Article www.ijptonline.com DESIGN AND EVALUATION OF GASTRORETENTIVE TABLETS FOR CONTROLLED DELIVERY OF NORFLOXOCIN Ganesh Kumar Gudas*, Subal Debnath,

More information

FORMULATION AND EVALUATION OF MELT-IN-MOUTH TABLETS OF DOMPERIDONE CONTAINING MULTICOMPONENT INCLUSION COMPLEX

FORMULATION AND EVALUATION OF MELT-IN-MOUTH TABLETS OF DOMPERIDONE CONTAINING MULTICOMPONENT INCLUSION COMPLEX Academic Sciences International Journal of Pharmacy and Pharmaceutical Sciences ISSN- 0975-1491 Vol 4, Issue 1, 2012 Research Article FORMULATION AND EVALUATION OF MELT-IN-MOUTH TABLETS OF DOMPERIDONE

More information

A FACTORIAL STUDY ON THE ENHANCEMENT OF DISSOLUTION RATE OF KETOPROFEN BY SOLID DISPERSION IN COMBINED CARRIERS

A FACTORIAL STUDY ON THE ENHANCEMENT OF DISSOLUTION RATE OF KETOPROFEN BY SOLID DISPERSION IN COMBINED CARRIERS Research Article A FACTORIAL STUDY ON THE ENHANCEMENT OF DISSOLUTION RATE OF KETOPROFEN BY SOLID DISPERSION IN COMBINED CARRIERS K. P. R. Chowdary *, Tanniru Adinarayana, T. Vijay, Mercy. R. Prabhakhar

More information

Volume: 2: Issue-3: July-Sept ISSN FORMULATION AND EVALUATION OF SUSTAINED RELEASE MATRIX TABLETS OF NICORANDIL

Volume: 2: Issue-3: July-Sept ISSN FORMULATION AND EVALUATION OF SUSTAINED RELEASE MATRIX TABLETS OF NICORANDIL Volume: 2: Issue-3: July-Sept -2011 ISSN 0976-4550 FORMULATION AND EVALUATION OF SUSTAINED RELEASE MATRIX TABLETS OF NICORANDIL Ajaykumar Patil*, Ashish Pohane, Ramya Darbar, Sharanya Koutika, Alekhya

More information

FORMULATION AND EVALUATION OF PIROXICAM AND CELECOXIB TABLETS EMPLOYING PROSOLVE BY DIRECT COMPRESSION METHOD

FORMULATION AND EVALUATION OF PIROXICAM AND CELECOXIB TABLETS EMPLOYING PROSOLVE BY DIRECT COMPRESSION METHOD Int. J. Chem. Sci.: 6(3), 2008, 1270-1275 FORMULATION AND EVALUATION OF PIROXICAM AND CELECOXIB TABLETS EMPLOYING PROSOLVE BY DIRECT COMPRESSION METHOD K. P. R. CHOWDARY, P. TRIPURA SUNDARI and K. SURYA

More information

FORMULATION AND EVALUATION OF ACECLOFENAC SODIUM BILAYER SUSTAINED RELEASE TABLETS

FORMULATION AND EVALUATION OF ACECLOFENAC SODIUM BILAYER SUSTAINED RELEASE TABLETS International Journal of ChemTech Research CODEN( USA): IJCRGG ISSN : 0974-4290 Vol.1, No.4, pp 1381-1385, Oct-Dec 2009 FORMULATION AND EVALUATION OF ACECLOFENAC SODIUM BILAYER SUSTAINED RELEASE TABLETS

More information

FORMULATION AND EVALUATION OF VALSARTAN TABLETS EMPLOYING CYCLODEXTRIN-POLOXAMER 407-PVP K30 INCLUSION COMPLEXES

FORMULATION AND EVALUATION OF VALSARTAN TABLETS EMPLOYING CYCLODEXTRIN-POLOXAMER 407-PVP K30 INCLUSION COMPLEXES Int. J. Chem. Sci.: 10(1), 2012, 297-305 ISSN 0972-768X www.sadgurupublications.com FORMULATION AND EVALUATION OF VALSARTAN TABLETS EMPLOYING CYCLODEXTRIN-POLOXAMER 407-PVP K30 INCLUSION COMPLEXES K. P.

More information

Design and development of fast Melting Tablets of Terbutaline Sulphate

Design and development of fast Melting Tablets of Terbutaline Sulphate Design and development of fast Melting Tablets of Terbutaline Sulphate Mathew T and Agrawal S Swami Vivekanand College of Pharmacy, Khandwa Road, Indore (MP), INDIA Available online at: www.isca.in (Received

More information

A FACTORIAL STUDY ON ENHANCEMENT OF SOLUBILITY AND DISSOLUTION RATE OF IBUPROFEN BY β CYCLODEXTRIN AND SOLUTOL HS15

A FACTORIAL STUDY ON ENHANCEMENT OF SOLUBILITY AND DISSOLUTION RATE OF IBUPROFEN BY β CYCLODEXTRIN AND SOLUTOL HS15 INTERNATIONAL JOURNAL OF RESEARCH IN PHARMACY AND CHEMISTRY Available online at www.ijrpc.com Research Article A FACTORIAL STUDY ON ENHANCEMENT OF SOLUBILITY AND DISSOLUTION RATE OF IBUPROFEN BY β CYCLODEXTRIN

More information

skim milk as carrier by kneading method. They were evaluated for percentage yield, drug content, FT-IR

skim milk as carrier by kneading method. They were evaluated for percentage yield, drug content, FT-IR Available Online through ISSN: 0975-766X CODEN: IJPTFI Research Article www.ijptonline.com ENHANCEMENT OF SOLUBILITY & DISSOLUTION RATE OF LAMOTRIGINE BY KNEADING METHOD Gadhave M.V*, Mahakal A. J., Gaikwad

More information

Improved Dissolution Properties of Ketoconazole through Application of Liquisolid Techniques

Improved Dissolution Properties of Ketoconazole through Application of Liquisolid Techniques Singh et al: Formulation and Evaluation of Buccoadhesive Tablets of Losartan Potassium 3053 International Journal of Pharmaceutical Sciences and Nanotechnology Volume 8 Issue 4 October December 2015 Research

More information

FACTORIAL STUDIES ON THE EFFECTS OF HYDROXY PROPYL β- CYCLODEXTRIN AND POLOXAMER 407 ON THE SOLUBILITY AND DISSOLUTION RATE OF BCS CLASS II DRUGS

FACTORIAL STUDIES ON THE EFFECTS OF HYDROXY PROPYL β- CYCLODEXTRIN AND POLOXAMER 407 ON THE SOLUBILITY AND DISSOLUTION RATE OF BCS CLASS II DRUGS JChrDD Vol 2 Issue 2 2011: 89-93 ISSN 2249-6785 Journal of Chronotherapy and Drug Delivery Received: August 06, 2011 Accepted: Sep 12, 2011 Original Research Paper FACTORIAL STUDIES ON THE EFFECTS OF HYDROXY

More information

FORMULATION AND EVALUATION OF CEFIXIME TRIHYDRATE ORAL DISINTEGRATING AGENTS

FORMULATION AND EVALUATION OF CEFIXIME TRIHYDRATE ORAL DISINTEGRATING AGENTS Academic Sciences International Journal of Pharmacy and Pharmaceutical Sciences ISSN- 0975-1491 Vol 4, Suppl 1, 2012 Research Article FORMULATION AND EVALUATION OF CEFIXIME TRIHYDRATE ORAL DISINTEGRATING

More information

INTERNATIONAL JOURNAL OF PHARMACY & LIFE SCIENCES

INTERNATIONAL JOURNAL OF PHARMACY & LIFE SCIENCES INTERNATIONAL JOURNAL OF PHARMACY & LIFE SCIENCES Formulation and In-Vitro evaluation of fast dissolving tablets of telmisartan Vishal Dhiman*, Gaurav Jain, Vaibhav Jagtap, R.V.Sheorey Department of Pharmaceutics,

More information

Preparation and Evaluation of Silymarin Controlled Release Tablets Prepared Using Natural Gums

Preparation and Evaluation of Silymarin Controlled Release Tablets Prepared Using Natural Gums 1368 International Journal of Pharmaceutical Sciences and Nanotechnology Volume 4 Issue 1 April-June 211 Research Paper International Journal of Pharmaceutical Sciences and Nanotechnology Volume 4 Issue

More information

Formulation and evaluation of oral dispersible tablets of aripiprazole

Formulation and evaluation of oral dispersible tablets of aripiprazole IJPAR Vol.6 Issue 2 April - June -17 Journal Home page: ISSN:23-2831 Research article Open Access Formulation and evaluation of oral dispersible tablets of aripiprazole A.Madhusudhan Reddy*, P.Srinivasababu,

More information

Karnataka Department of Pharmaceutical Technology, H.K.E. Society s College of Pharmacy, Gulbarga, Karnataka ABSTRACT KEYWORDS:

Karnataka Department of Pharmaceutical Technology, H.K.E. Society s College of Pharmacy, Gulbarga, Karnataka ABSTRACT KEYWORDS: 335 P a g e International Standard Serial Number (ISSN): 2319-8141 International Journal of Universal Pharmacy and Bio Sciences 4(6): November-December 2015 INTERNATIONAL JOURNAL OF UNIVERSAL PHARMACY

More information

Int. Res J Pharm. App Sci., 2013; 3(6):42-46 ISSN:

Int. Res J Pharm. App Sci., 2013; 3(6):42-46 ISSN: International Research Journal of Pharmaceutical and Applied Sciences (IRJPAS) Available online at www.irjpas.com Int. Res J Pharm. App Sci., 2013; 3(6):42-46 Research Article ENHANCEMENT OF SOLUBILITY

More information

Received on: Accepted on:

Received on: Accepted on: ISSN: 0975-766X CODEN: IJPTFI Available Online through Research Article www.ijptonline.com FORMULATION, EVALUATION AND OPTIMIZATION OF ORODISPERSIBLE TABLET CONTAINING ANTI-EMETIC DRUG Imran AM* 1, Sudhakar

More information

Chemate and Chowdary, IJPSR, 2012; Vol. 3(7): ISSN:

Chemate and Chowdary, IJPSR, 2012; Vol. 3(7): ISSN: IJPSR (2012), Vol. 3, Issue 07 (Research Article) Received on 18 March, 2012; received in revised form 25 April, 2012; accepted 22 June, 2012 A FACTORIAL STUDY ON ENHANCEMENT OF SOLUBILITY AND DISSOLUTION

More information

B. Jayakar et. al. FORMULATION AND EVALUATION OF ORODISPERSIBLE TABLET OF CELECOXIB R. Margret Chandira, Shyam Sharma, Debjit Bhowmik, B.

B. Jayakar et. al. FORMULATION AND EVALUATION OF ORODISPERSIBLE TABLET OF CELECOXIB R. Margret Chandira, Shyam Sharma, Debjit Bhowmik, B. Page117 Online Available at www.thepharmaresearch.info THE PHARMA RESEARCH, A JOURNAL The Pharma Research (T. Ph. Res.), (2010), 4; 117-122. Published on- 15 Dec 2010 Copyright 2009 by Sudarshan Publication

More information

Formulation and In-vitro Evaluation of Chewable Tablets of Montelukast Sodium

Formulation and In-vitro Evaluation of Chewable Tablets of Montelukast Sodium Available online on www.ijddt.com International Journal of Drug Delivery Technology 214; (3); 98-13 Research Article ISSN: 97 441 Formulation and In-vitro Evaluation of Chewable Tablets of Montelukast

More information

Pavan K et al IJARPB: 2013, 3(2), ISSN: Available online on Research Article

Pavan K et al IJARPB: 2013, 3(2), ISSN: Available online on  Research Article Available online on www.ijarpb.com Research Article Received on 15/01/2013; Revised on 23/01/2013; Accepted on 27/01/2013; Fast Dissolving Tablets Of Pioglitazone Hydrochloride By Use Of Various Superdisintegrants

More information

Volume: I: Issue-2: Aug-Oct ISSN NOVEL APPROACH IN FORMULATION AND EVALUATION OF MOUTH DISSOLVING TABLETS OF ONDANSETRON HYDROCHLORIDE

Volume: I: Issue-2: Aug-Oct ISSN NOVEL APPROACH IN FORMULATION AND EVALUATION OF MOUTH DISSOLVING TABLETS OF ONDANSETRON HYDROCHLORIDE Volume: I: Issue-2: Aug-Oct -2010 ISSN 0976-4550 NOVEL APPROACH IN FORMULATION AND EVALUATION OF MOUTH DISSOLVING TABLETS OF ONDANSETRON HYDROCHLORIDE * Hindustan Abdul Ahad, Anuradha CM, Chitta Suresh

More information

Formulation and evaluation of mouth dissolving tablets containing losartan potassium

Formulation and evaluation of mouth dissolving tablets containing losartan potassium Available online at www.scholarsresearchlibrary.com Scholars Research Library Der Pharmacia Lettre, 2016, 8 (17):115-123 (http://scholarsresearchlibrary.com/archive.html) ISSN 0975-5071 USA CODEN: DPLEB4

More information

EVALUATION OF EFFERVESCENT FLOATING TABLETS. 6.7 Mathematical model fitting of obtained drug release data

EVALUATION OF EFFERVESCENT FLOATING TABLETS. 6.7 Mathematical model fitting of obtained drug release data EVALUATION OF EFFERVESCENT FLOATING TABLETS 6.1 Technological characteristics of floating tablets 6.2 Fourier transform infrared spectroscopy (FT-IR) 6.3 Differential scanning calorimetry (DSC) 6.4 In

More information

ENHANCEMENT OF SOLUBILITY AND DISSOLUTION RATE OF NIMESULIDE BY CYCLODEXTRINS, POLOXAMER AND PVP

ENHANCEMENT OF SOLUBILITY AND DISSOLUTION RATE OF NIMESULIDE BY CYCLODEXTRINS, POLOXAMER AND PVP Int. J. Chem. Sci.: 9(2), 20, 637-646 ISSN 0972-768X www.sadgurupublications.com ENHANCEMENT OF SOLUBILITY AND DISSOLUTION RATE OF NIMESULIDE BY CYCLODEXTRINS, POLOXAMER AND PVP K. P. R. CHOWDARY *, K.

More information

A STUDY ON SUITABILITY OF NIMESULIDE-BETACYCLODEXTRIN COMPLEX IN ORAL AND TOPICAL DOSAGE FORMS

A STUDY ON SUITABILITY OF NIMESULIDE-BETACYCLODEXTRIN COMPLEX IN ORAL AND TOPICAL DOSAGE FORMS International Journal of Pharmacy and Pharmaceutical Sciences, Vol. 1, Suppl 1, Nov.-Dec. 2009 Research Article A STUDY ON SUITABILITY OF NIMESULIDE-BETACYCLODEXTRIN COMPLEX IN ORAL AND TOPICAL DOSAGE

More information

Formulation and Evaluation of Glicazide Mouth Dissolving Tablets

Formulation and Evaluation of Glicazide Mouth Dissolving Tablets Research Article Vishakha S. Hastak*, Yogyata S. Pathare, Kiran C. Mahajan Department of Pharmaceutics, Shree Chanakya Education Society's Indira college of Pharmacy, Tathawade, Pune, Maharashtra, India.

More information

Asian Journal of Pharmacy and Life Science ISSN Vol. 2 (2), July-Sept,2012

Asian Journal of Pharmacy and Life Science ISSN Vol. 2 (2), July-Sept,2012 STUDIES ON EFFECT OF SUPERDISINTEGRANTS ON ETORICOXIB TABLET FORMULATIONS Chowdary K. P. R 1, Venugopal. K *2 1 College of Pharmaceutical Sciences, Andhra University, Vishakapattanam. 2 * Nirmala college

More information

Comparative study of different solubility enhancement techniques on dissolution rate of zaltoprofen

Comparative study of different solubility enhancement techniques on dissolution rate of zaltoprofen World Journal of Pharmaceutical Sciences ISSN (Print): 2321-3310; ISSN (Online): 2321-3086 Published by Atom and Cell Publishers All Rights Reserved Available online at: http://www.wjpsonline.org/ Original

More information

Journal of Global Trends in Pharmaceutical Sciences Vol.2, Issue 4, pp , Oct -Dec 2011

Journal of Global Trends in Pharmaceutical Sciences Vol.2, Issue 4, pp , Oct -Dec 2011 ISSN: 223-7346 Research Article Journal of Global Trends in Pharmaceutical Sciences Vol.2, Issue 4, pp -394-43, Oct -Dec 211 FORMULATION AND INVITRO EVALUATION OF SUSTAINED RELEASE MATRIX TABLETS OF GLIMEPIRIDE

More information

Optimization of valsartan tablet formulation by 2 3 factorial design

Optimization of valsartan tablet formulation by 2 3 factorial design Research Article ISSN: 0974-6943 K. P. R. Chowdary et al. / Journal of Pharmacy Research 2014,8(9, Available online through http://jprsolutions.info Optimization of valsartan tablet formulation by 2 3

More information

FORMULATION AND EVALUATION OF ETORICOXIB TABLETS EMPLOYING CYCLODEXTRIN- POLOXAMER PVPK30 INCLUSION COMPLEXES

FORMULATION AND EVALUATION OF ETORICOXIB TABLETS EMPLOYING CYCLODEXTRIN- POLOXAMER PVPK30 INCLUSION COMPLEXES Volume: 2: Issue-4: Oct - Dec -2011 ISSN 0976-4550 FORMULATION AND EVALUATION OF ETORICOXIB TABLETS EMPLOYING CYCLODEXTRIN- POLOXAMER 407 - PVPK30 INCLUSION COMPLEXES K.P.R. Chowdary*, K. Surya Prakasa

More information

Research Journal of Pharmaceutical, Biological and Chemical Sciences

Research Journal of Pharmaceutical, Biological and Chemical Sciences Research Journal of Pharmaceutical, Biological and Chemical Sciences Development and characterisation of oral fast dissolving tablet of nifedipine using camphor as a subliming material Shinde Anilkumar

More information

Int. Res J Pharm. App Sci., 2014; 4(1):47-51 ISSN:

Int. Res J Pharm. App Sci., 2014; 4(1):47-51 ISSN: International Research Journal of Pharmaceutical and Applied Sciences (IRJPAS) Available online at www.irjpas.com Int. Res J Pharm. App Sci., 2014; 4(1):47-51 Research Article FORMULATION AND EVALUATION

More information

DEVELOPMENT OF NON SODIUM EFFERVESCENT TABLET OF PARACETAMOL USING ARGININE CARBONATE

DEVELOPMENT OF NON SODIUM EFFERVESCENT TABLET OF PARACETAMOL USING ARGININE CARBONATE IJPSR (2013), Vol. 4, Issue 5 (Research Article) Received on 17 July, 2012; received in revised form, 23 February, 2013; accepted, 14 April, 2013 DEVELOPMENT OF NON SODIUM EFFERVESCENT TABLET OF PARACETAMOL

More information

3.1 Background. Preformulation Studies

3.1 Background. Preformulation Studies Preformulation Studies 3.1 Background Delivery of any drug requires a suitable dosage form to get optimum therapeutic effects. The development of such dosage forms fundamental properties of the drug molecule

More information

Journal of Advanced Scientific Research. Formulation and Evaluation of Glimepiride Solid Dispersion Tablets for Their Solubility Enhancement

Journal of Advanced Scientific Research. Formulation and Evaluation of Glimepiride Solid Dispersion Tablets for Their Solubility Enhancement Wagh V.T. et al, J Adv Sci Res, 2012, 3(4): 36-41 36 Journal of Advanced Scientific Research Available online through http://www.sciensage.info/jasr ISSN 0976-9595 Research Article Formulation and Evaluation

More information

DESIGNING OF ORODISPERSIBLE TABLET OF DIETHYL CARBAMAZINE CITRATE FOR THE TREATMENT OF FILARIASIS

DESIGNING OF ORODISPERSIBLE TABLET OF DIETHYL CARBAMAZINE CITRATE FOR THE TREATMENT OF FILARIASIS Volume: 2: Issue-4: Oct - Dec -2011 ISSN 0976-4550 DESIGNING OF ORODISPERSIBLE TABLET OF DIETHYL CARBAMAZINE CITRATE FOR THE TREATMENT OF FILARIASIS Chinmaya Keshari Sahoo* 1, Tanmaya Keshari Sahoo 2 and

More information

A Comparative Evaluation of Cross Linked Starch Urea-A New Polymer and Other Known Polymers for Controlled Release of Diclofenac

A Comparative Evaluation of Cross Linked Starch Urea-A New Polymer and Other Known Polymers for Controlled Release of Diclofenac Asian Journal of Chemistry Vol. 22, No. 6 (2010), 4239-4244 A Comparative Evaluation of Cross Linked Starch Urea-A New Polymer and Other Known Polymers for Controlled Release of Diclofenac K.P.R. CHOWDARY*

More information

STUDIES ON EFFECT OF BINDERS ON ETORICOXIB TABLET FORMULATIONS

STUDIES ON EFFECT OF BINDERS ON ETORICOXIB TABLET FORMULATIONS Int. J. Chem. Sci.: 10(4), 2012, 1934-1942 ISSN 0972-768X www.sadgurupublications.com STUDIES ON EFFECT OF BINDERS ON ETORICOXIB TABLET FORMULATIONS K. VENUGOPAL * and K. P. R. CHOWDARY a Nirmala College

More information

Formulation and evaluation of Orodispersible tablets to enhance dissolution rate of Lamotrigine by using Solid Dispersion Technique

Formulation and evaluation of Orodispersible tablets to enhance dissolution rate of Lamotrigine by using Solid Dispersion Technique 35 Formulation and evaluation of Orodispersible tablets to enhance dissolution rate of Lamotrigine by using Solid Dispersion Technique Bhumi B. Patel 1 *, Chainesh N. Shah 2, Rumit M. Shah 3 1 Department

More information

Formulation Development, Evaluation and Comparative Study of Effects of Super Disintegrants in Cefixime Oral Disintegrating Tablets

Formulation Development, Evaluation and Comparative Study of Effects of Super Disintegrants in Cefixime Oral Disintegrating Tablets Pharmaceutics Formulation Development, Evaluation and Comparative Study of Effects of Super Disintegrants in Cefixime Oral Disintegrating Tablets Remya KS, Beena P, Bijesh PV, Sheeba A Nazareth College

More information

INTERNATIONAL RESEARCH JOURNAL OF PHARMACY ISSN Research Article

INTERNATIONAL RESEARCH JOURNAL OF PHARMACY  ISSN Research Article INTERNATIONAL RESEARCH JOURNAL OF PHARMACY www.irjponline.com ISSN 2230 8407 Research Article FORMULATION AND EVALUATION OF IMMEDIATE RELEASE VENLAFAXINE HCL TABLETS: COMPARATIVE STUDY OF SUPER DISINTEGRANT

More information

Patel B et al. IRJP 1 (1)

Patel B et al. IRJP 1 (1) INTERNATIONAL RESEARCH JOURNAL OF PHARMACY Available online http://www.irjponline.com Research Article IMPROVEMENT OF SOLUBILITY OF CINNARIZINE BY USING SOLID DISPERSION TECHNIQUE Patel Bipin*, Patel Jayvadan,

More information

Formulation and Evaluation of Oral disintegrated tablets of Alfuzosin Hydrochloride using superdisintegrants

Formulation and Evaluation of Oral disintegrated tablets of Alfuzosin Hydrochloride using superdisintegrants ISSN: 2231-3354 Received on: 13-11-2011 Revised on: 18:11:2011 Accepted on: 22-11-2011 Formulation and Evaluation of Oral disintegrated tablets of Alfuzosin Hydrochloride using superdisintegrants Leela

More information

Formulation Development of Aceclofenac Tablets Employing Starch Phosphate -A New Modified Starch

Formulation Development of Aceclofenac Tablets Employing Starch Phosphate -A New Modified Starch Abstract K.P.R. Chowdary et al. / International Journal of Pharma Sciences and Research (IJPSR) Formulation Development of Aceclofenac Tablets Employing Starch Phosphate -A New Modified Starch K.P.R. Chowdary*,

More information

FORMULATION AND EVALUATION OF BILAYERED TABLET OF METFORMIN HYDROCHLORIDE AND PIOGLITAZONE HYDROCHLORIDE

FORMULATION AND EVALUATION OF BILAYERED TABLET OF METFORMIN HYDROCHLORIDE AND PIOGLITAZONE HYDROCHLORIDE Academic Sciences International Journal of Pharmacy and Pharmaceutical Sciences ISSN- 975-1491 Vol 4, Suppl 5, 212 FORMULATION AND EVALUATION OF BILAYERED TABLET OF METFORMIN HYDROCHLORIDE AND PIOGLITAZONE

More information

Development and characterization of orodispersible tablets of famotidine containing a subliming agent

Development and characterization of orodispersible tablets of famotidine containing a subliming agent Adisa et al Tropical Journal of Pharmaceutical Research, December 2008; 7 (4): 1185-1189 Pharmacotherapy Group, Faculty of Pharmacy, University of Benin, Benin City, 300001 Nigeria. All rights reserved.

More information

FORMULATION DEVELOPMENT AND EVALUATION OF MOUTH DISSOLVING TABLET OF TRAMADOL HYDROCHLORIDE

FORMULATION DEVELOPMENT AND EVALUATION OF MOUTH DISSOLVING TABLET OF TRAMADOL HYDROCHLORIDE Vol 6, Suppl 3, 2013 ISSN - 0974-2441 Research Article FORMULATION DEVELOPMENT AND EVALUATION OF MOUTH DISSOLVING TABLET OF TRAMADOL HYDROCHLORIDE ABSTRACT SONALI J. SHAH *, RUPA MAZUMDER Department of

More information

FORMULATION AND DEVELOPMENT OF ER METOPROLAOL SUCCINATE TABLETS

FORMULATION AND DEVELOPMENT OF ER METOPROLAOL SUCCINATE TABLETS International Journal of PharmTech Research CODEN( USA): IJPRIF ISSN : 0974-4304 Vol.1, No.3, pp 634-638, July-Sept 2009 FORMULATION AND DEVELOPMENT OF ER METOPROLAOL SUCCINATE TABLETS K. Reeta Vijaya

More information

Scholars Research Library

Scholars Research Library Available online at www.scholarsresearchlibrary.com Scholars Research Library Der Pharmacia Lettre, 2010: 2 (1) 528-539 (http://scholarsresearchlibrary.com/archive.html) ISSN 0975-5071 USA CODEN: DPLEB4

More information

Formulation and Evaluation of Mouth Dissolving Sublingual Tablets of Cimetidine to Treat Abdominal Cramps

Formulation and Evaluation of Mouth Dissolving Sublingual Tablets of Cimetidine to Treat Abdominal Cramps International Journal of Pharmaceutical Science Invention ISSN (Online): 2319 6718, ISSN (Print): 2319 670X Volume 3 Issue 9 September 2014 PP.41-46 Formulation and Evaluation of Mouth Dissolving Sublingual

More information

Mixed Hydrotropy: Novel Science of Solubility Enhancement

Mixed Hydrotropy: Novel Science of Solubility Enhancement Research Paper Mixed Hydrotropy: Novel Science of Solubility Enhancement R. K. MAHESHWARI* AND Y. JAGWANI Shri G. S. Institute of Technology and Science, 23-Park Road, Indore-452 003, Madhya Pradesh, India

More information

Design and In-vitro Evaluation of Silymarin Bilayer Tablets

Design and In-vitro Evaluation of Silymarin Bilayer Tablets CODEN (USA)-IJPRUR, e-issn: 2348-6465 International Journal of Pharma Research and Health Sciences Available online at www.pharmahealthsciences.net Original Article Design and In-vitro Evaluation of Silymarin

More information

Maisammaguda, Dulapally, Secundrabad.

Maisammaguda, Dulapally, Secundrabad. 121 P a g e International Standard Serial Number (ISSN): 2319-8141 International Journal of Universal Pharmacy and Bio Sciences 3(6): November-December 2014 INTERNATIONAL JOURNAL OF UNIVERSAL PHARMACY

More information

Scholars Research Library. Formulation Development of Pioglitazone Tablets Employing β Cyclodextrin- Poloxamer 407- PVP K30: A Factorial Study

Scholars Research Library. Formulation Development of Pioglitazone Tablets Employing β Cyclodextrin- Poloxamer 407- PVP K30: A Factorial Study Available online at www.scholarsresearchlibrary.com Scholars Research Library Der Pharmacia Lettre, 2011, 3 (6):24-30 (http:scholarsresearchlibrary.comarchive.html) ISSN 0974-248X USA CODEN: DPLEB4 Formulation

More information

Formulation and Optimization of Lamotrigin Fast Dissolving Tablet

Formulation and Optimization of Lamotrigin Fast Dissolving Tablet Formulation and Optimization of Lamotrigin Fast Dissolving Tablet Sachin S. Gupta 1, Hitesh Patel 2, B.G.Prajapati 2, Shreeraj Shah 1 1. L.J.Institute of Pharmacy.Sanand Cross road, Sarkhej-Gandhinagar

More information

Available Online through

Available Online through ISSN: 0975-766X Available Online through Research Article www.ijptonline.com FORMULATION DESIGN AND OPTIMIZATION OF MOUTH DISSOLVE TABLETS OF GLIPIZIDE R.Shireesh Kiran 1*, B.Chander Shekar 1, Sharadha

More information

International Journal of Medicine and Pharmaceutical Research

International Journal of Medicine and Pharmaceutical Research International Journal of Medicine and Pharmaceutical Research Journal Home Page: www.pharmaresearchlibrary.com/ijmpr Research Article Open Access Formulation and Evaluation of Gastroretentive Floating

More information

FORMULATION AND EVALUATION OF DILTIAZEM HYDROCHLORIDE COLON TARGETED TABLETS

FORMULATION AND EVALUATION OF DILTIAZEM HYDROCHLORIDE COLON TARGETED TABLETS INTERNATIONAL JOURNAL OF RESEARCH IN PHARMACY AND CHEMISTRY Available online at www.ijrpc.com Research Article FORMULATION AND EVALUATION OF DILTIAZEM HYDROCHLORIDE COLON TARGETED TABLETS G. Subba Rao

More information

Formulation Development and Evaluation of Sustained Release Matrix Tablets of Guaiphenesin

Formulation Development and Evaluation of Sustained Release Matrix Tablets of Guaiphenesin 3312 Int J Pharm Sci Nanotech Vol 9; Issue 3 May June 2016 International Journal of Pharmaceutical Sciences and Nanotechnology Research Paper Volume 9 Issue 3 May June 2016 MS ID: IJPSN-4-6-16-BASARKAR

More information

Int. Res J Pharm. App Sci., 2012; 2(6): ISSN:

Int. Res J Pharm. App Sci., 2012; 2(6): ISSN: International Research Journal of Pharmaceutical and Applied Sciences (IRJPAS) Available online at www.irjpas.com Int. Res J Pharm. App Sci., 2013; 3(1): 269-273 Research Article FORMULATION DEVELOPMENT

More information

Optimization of Atenolol Core Tablet CHAPTER 5: OPTIMIZATION OF FORMULATION OF ATENOLOL CORE TABLETS

Optimization of Atenolol Core Tablet CHAPTER 5: OPTIMIZATION OF FORMULATION OF ATENOLOL CORE TABLETS CHAPTER 5: OPTIMIZATION OF FORMULATION OF ATENOLOL CORE TABLETS 5.1. AIM OF THE STUDY The pulsatile type press coated colon targeted atenolol tablet release drug after 6 hr lag time. The compression coated

More information

International Journal of Pharma Sciences and Scientific Research

International Journal of Pharma Sciences and Scientific Research Research Article International Journal of Pharma Sciences and Scientific Research ISSN 2471-6782 Open Access Formulation, development and evaluation of rivaroxaban tablets by using solubility enhancement

More information

ENHANCEMENT OF SOLUBILITY OF BICALUTAMIDE DRUG USING SOLID DISPERSION TECHNIQUE

ENHANCEMENT OF SOLUBILITY OF BICALUTAMIDE DRUG USING SOLID DISPERSION TECHNIQUE PHARMA SCIENCE MONITOR AN INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES ENHANCEMENT OF SOLUBILITY OF BICALUTAMIDE DRUG USING SOLID DISPERSION TECHNIQUE Kantilal B. Narkhede *1, R. B. Laware 2, Y. P.

More information

The purpose of the present investigation was to design a formulation of orodispersible tablets of Etoricoxib by adopting

The purpose of the present investigation was to design a formulation of orodispersible tablets of Etoricoxib by adopting Research ARTICLE Formulation design and optimization of orodispersible tablets of etoricoxib by response surface methodology S R Shahi, G R Agrawal, N V Shinde, S A Shaikh 1, S S Shaikh, A N Padalkar 3,

More information

FORMULATION DEVELOPMENT AND IN-VITRO EVALUATION OF ORALLY DISINTEGRATING TABLETS OF AMLODIPINE BESYLATE

FORMULATION DEVELOPMENT AND IN-VITRO EVALUATION OF ORALLY DISINTEGRATING TABLETS OF AMLODIPINE BESYLATE INTERNATIONAL JOURNAL OF RESEARCH IN PHARMACY AND CHEMISTRY Available online at www.ijrpc.com Research Article FORMULATION DEVELOPMENT AND IN-VITRO EVALUATION OF ORALLY DISINTEGRATING TABLETS OF AMLODIPINE

More information

Available online at

Available online at Available online at www.jgtps.com Research Article ISSN:2230-7346 Journal of Global Trends in Pharmaceutical Sciences Vol.3, Issue 4, pp -923-928, October December 202 ENHANCEMENT OF DISSOLUTION RATE OF

More information

Formulation and Evaluation of Etoricoxib Oro Dispersable Tablets by Direct Compression Method

Formulation and Evaluation of Etoricoxib Oro Dispersable Tablets by Direct Compression Method IOSR Journal of Pharmacy and Biological Sciences (IOSR-JPBS) e-issn:2278-3008, p-issn:2319-7676. Volume 11, Issue 2 Ver. III (Mar.- Apr.2016), PP 64-70 www.iosrjournals.org Formulation and Evaluation of

More information

Research Article. Formulation and Evaluation of Oral Dispersible Tablets of Zidovudine with different Superdisintegrants.

Research Article. Formulation and Evaluation of Oral Dispersible Tablets of Zidovudine with different Superdisintegrants. Available online on www.ijcpr.com (ISSN: 0976 822X) International Journal of Current Pharmaceutical Review and Research Volume 2, Issue 2, May - July 2011 Research Article Formulation and Evaluation of

More information

DESIGN AND EVALUATION OF CONTROLLED RELEASE MATRIX TABLETS OF FLURBIPROFEN

DESIGN AND EVALUATION OF CONTROLLED RELEASE MATRIX TABLETS OF FLURBIPROFEN Int. J. Chem. Sci.: 10(4), 2012, 2199-2208 ISSN 0972-768X www.sadgurupublications.com DESIGN AND EVALUATION OF CONTROLLED RELEASE MATRIX TABLETS OF FLURBIPROFEN K. V. R. N. S. RAMESH *, B. HEMA KIRNAMAYI

More information

Journal of Pharmaceutical and Scientific Innovation

Journal of Pharmaceutical and Scientific Innovation Journal of Pharmaceutical and Scientific Innovation www.jpsionline.com (ISSN : 2277 4572) Research Article ASSESSING THE BEST POLY VINYL PYRROLIDONE AS A CARRIER FOR ETORICOXIB SOLID DISPERSIONS: FABRICATION

More information

Formulation and evaluation of intraorally fast dissolving tablet of olmesartan medoxomil

Formulation and evaluation of intraorally fast dissolving tablet of olmesartan medoxomil Available online at www.scholarsresearchlibrary.com Scholars Research Library Der Pharmacia Lettre, 2013, 5 (1):232-237 (http://scholarsresearchlibrary.com/archive.html) ISSN 0975-5071 USA CODEN: DPLEB4

More information

INTERNATIONAL JOURNAL OF PHARMACEUTICAL AND CHEMICAL SCIENCES

INTERNATIONAL JOURNAL OF PHARMACEUTICAL AND CHEMICAL SCIENCES Research Article Formulation, Development and Evaluation of Fast Dissolving Tablet of Salbutamol Sulphate by Using Superdisintegrants of Various Concentrations Santosh K 1 *, Meenakshi B 2 and Jyoti M

More information

Formulation, Optimization and Evaluation of Mouth Dissolving Tablet of Zidovudine

Formulation, Optimization and Evaluation of Mouth Dissolving Tablet of Zidovudine Formulation, Optimization and Evaluation of Mouth Dissolving Tablet of Zidovudine Mayur V. Chinchore*, Sanjay P. Aher, Chetan P. Mahajan, Ghanshyam J. Yadav, Avish D. Maru Department of Pharmaceutics,

More information

Effect of superdisintegrants and their mode of incorporation on disintegration time and release profile of carbamazepine from immediate release tablet

Effect of superdisintegrants and their mode of incorporation on disintegration time and release profile of carbamazepine from immediate release tablet Journal of Applied Pharmaceutical Science Vol. 3 (5), pp. -84, May, 213 Available online at http://www.japsonline.com DOI: 1.7324/JAPS.213.3515 ISSN 2231-3354 Effect of superdisintegrants and their mode

More information

International Journal of Pharma and Bio Sciences V1(1)2010 FORMULATION AND EVALUATION OF ROSIGLITAZONE MOUTH DISSOLVING TABLET

International Journal of Pharma and Bio Sciences V1(1)2010 FORMULATION AND EVALUATION OF ROSIGLITAZONE MOUTH DISSOLVING TABLET G ARJUN 1*, M.SRAVAN PRASAD 1, D SANTHOSHA 1 AND G.ACHAIAH 2 1 Nalanda college of pharmacy, Osmania University, Nalgonda, India. 2 University College of Pharmaceutical Sciences, Kakatiya University, Warangal,

More information

Received on: Accepted on:

Received on: Accepted on: ISSN: 0975-766X CODEN: IJPTFI Available Online through Research Article www.ijptonline.com DESIGN AND EVALUATION OF OPTIMIZED FAST DISSOLVING TABLETS OF SALBUTAMOL SULPHATE Imran AM* 1, Sudhakar P 2 and

More information

International Journal of Biopharmaceutics. Journal homepage:

International Journal of Biopharmaceutics. Journal homepage: 59 e- ISSN 0976-1047 Print ISSN 2229-7499 International Journal of Biopharmaceutics Journal homepage: www.ijbonline.com IJB FORMULATION AND EVALUATION OF PROMETHAZINE HCl FAST DISINTEGRATING SUBLINGUAL

More information

Formulation and Evaluation of Gastroretentive Dosage form of Ciprofloxacin Hydrochloride.

Formulation and Evaluation of Gastroretentive Dosage form of Ciprofloxacin Hydrochloride. Available online on www.ijcpr.com International Journal of Current Pharmaceutical Review and Research, 3(4), 105-109 Research Article ISSN: 0976-822X Formulation and Evaluation of Gastroretentive Dosage

More information

Journal of Pharmaceutical and Scientific Innovation

Journal of Pharmaceutical and Scientific Innovation Journal of Pharmaceutical and Scientific Innovation www.jpsionline.com Research Article ENHANCEMENT OF SOLUBILITY AND DISSOLUTION RATE OF ROSUVASTATIN BY USING SOLID DISPERSION TECHNIQUE Swathi T 1 *,

More information

OPTIMIZATION OF CONTROLLED RELEASE GASTRORETENTIVE BUOYANT TABLET WITH XANTHAN GUM AND POLYOX WSR 1105

OPTIMIZATION OF CONTROLLED RELEASE GASTRORETENTIVE BUOYANT TABLET WITH XANTHAN GUM AND POLYOX WSR 1105 Digest Journal of Nanomaterials and Biostructures Vol. 9, No. 3, July September 2014, p. 1077-1084 OPTIMIZATION OF CONTROLLED RELEASE GASTRORETENTIVE BUOYANT TABLET WITH XANTHAN GUM AND POLYOX WSR 1105

More information

International Journal of Institutional Pharmacy and Life Sciences 3(6): November-December 2013

International Journal of Institutional Pharmacy and Life Sciences 3(6): November-December 2013 International Journal of Institutional Pharmacy and Life Sciences 3(6): November-December 2013 INTERNATIONAL JOURNAL OF INSTITUTIONAL PHARMACY AND LIFE SCIENCES Pharmaceutical Sciences Research Article!!!

More information

May Vol: 06 Issue: 01 (1-12)

May Vol: 06 Issue: 01 (1-12) May 16 Vol: 6 Issue: 1 (1-1) RESEARCH PAPER Formulation and Evaluation of Extended Release Tablets of Metformin HCl Anamika Chouhan*1, Deepak Marothia1, Khushboo Ranka1, Kamal Singh Rathore 1Department

More information

INTERNATIONAL JOURNAL OF INSTITUTIONAL PHARMACY AND LIFE SCIENCES

INTERNATIONAL JOURNAL OF INSTITUTIONAL PHARMACY AND LIFE SCIENCES International Journal of Institutional Pharmacy and Life Sciences 6(2): March-April 2016 INTERNATIONAL JOURNAL OF INSTITUTIONAL PHARMACY AND LIFE SCIENCES Pharmaceutical Sciences Research Article!!! Received:

More information